Related Experiment Video
Updated: Mar 29, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
RSV vaccine use--the missing data
Simon B Drysdale1,2, Charles J Sande1, Christopher A Green1
1a Oxford Vaccine Group, Department of Paediatrics , University of Oxford , Oxford , UK.
Insights
Respiratory syncytial virus (RSV) is a major cause of infant hospitalizations and mortality globally. More data on RSV epidemiology, transmission, and costs are needed to guide effective vaccination strategies and public health policy.
Area of Science:
- * Virology and Epidemiology
- * Public Health and Vaccinology
Background:
- * Respiratory syncytial virus (RSV) is a primary driver of infant hospitalizations and a leading cause of global infant mortality.
- * Prevention via vaccination is a critical public health objective, yet implementation faces data gaps.
Purpose of the Study:
- * To highlight the need for comprehensive epidemiological data on RSV.
- * To underscore the importance of understanding RSV transmission dynamics and associated healthcare costs.
- * To inform the development of effective vaccination strategies and health economic models for RSV control.
Main Methods:
- * Review of existing literature on RSV epidemiology and disease burden.
- * Identification of critical data gaps in understanding RSV transmission and economic impact.
- * Emphasis on the necessity of data for health economic modeling.
Main Results:
- * Significant lack of detailed epidemiological data across diverse settings and age groups for RSV.
- * Limited understanding of RSV transmission patterns and the economic burden of the disease.
- * Urgent requirement for data to support vaccine program implementation and policy decisions.
Conclusions:
- * Robust epidemiological data is essential for successful RSV vaccination programs.
- * Further research is needed to quantify RSV transmission and healthcare costs.
- * Data-driven insights are crucial for optimizing public health interventions against RSV.
Abstract:
Respiratory syncytial virus (RSV) infection is the most important cause of hospitalization in infants and is one of the leading global causes of infant mortality and as such its prevention through vaccination is a public health priority. While essential for the successful implementation of vaccine programs, there remains a paucity of data on the epidemiology of the virus in different settings and age groups and limited knowledge about virus transmission and the health-care costs of the disease. Such data are now needed to populate health economic models and to inform optimal approaches to disease control through vaccination.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Vaccinations
Vaccines

